Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
684
datasets available to search
ShareScore release 0.7.1
Dataset results
684 results for “Vomiting”
Transcutaneous Electrical Acupoint Stimulation of P6 to Prevent Postoperation Nausea and Vomiting
ClinicalTrials.gov study NCT02096835. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Auricular Neurostimulation for Cyclic Vomiting Syndrome
ClinicalTrials.gov study NCT03434652. IPD Sharing: NO. Countries: 1. Publications: 5.
Study of the Effect of Intramuscular Ephedrine on the Incidence of Nausea and Vomiting During Elective Cesarean Section
ClinicalTrials.gov study NCT00432991. IPD Sharing: NO. Countries: 1. Publications: 1.
Capsaicin Cream as an Adjunctive Therapy for Nausea and Vomiting of Pregnancy
ClinicalTrials.gov study NCT05098067. IPD Sharing: UNDECIDED. Countries: 1. Publications: 9.
Acupuncture Point P6 Stimulation for Reduction of Nausea and Vomiting During Cesarean
ClinicalTrials.gov study NCT02959840. IPD Sharing: NO. Countries: 1. Publications: 16.
Netupitant and Palonosetron Hydrochloride in Preventing Chronic Nausea and Vomiting in Patients With Cancer
ClinicalTrials.gov study NCT03040726. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)
ClinicalTrials.gov study NCT00895830. IPD Sharing: Not stated. Countries: 4. Publications: 1.
BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or Gastritis
ClinicalTrials.gov study NCT02246439. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Acupuncture for Chemotherapy-Induced Nausea and Vomiting
ClinicalTrials.gov study NCT02195921. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Data from: Ambulatory versus inpatient management of severe nausea and vomiting of pregnancy: a randomized control trial with patient preference arm
ABSTRACT Objective To determine whether ambulatory (outpatient, OP) treatment of severe nausea and vomiting of pregnancy (NVP) is as effective as inpatient (IP) care. Design Non-blinded randomized control trial (RCT) with patient preference arm Setting Multi-center Participants Women less than 20 weeks pregnant with severe NVP and associated ketonuria Methods Women participating in the RCT were randomized via web-based application to either ambulatory or IP treatment. Women declining randomisation entered the patient preference trial (PPT) arm. Protocols, data collection and follow-up were the same for all participants. Main Outcome Measures Primary outcome was reduction in Pregnancy Unique Quantification of Emesis (PUQE) score at 48 hours. Secondary outcomes were duration of treatment; improvement in symptom scores and ketonuria at 48 hours; re-attendances within 7 days of discharge; and comparison of symptoms at 7 days post discharge Results 152/174 eligible women agreed to participate with 77/152 (51%) recruited to the RCT and 79/152 (49%) to the PPT. Patients were initially compared in 4 groups (randomized IP, randomized OP, non-randomized IP and non-randomized OP). Comprehensive cohort analysis of participants in the (RCT) and (PPT) did not demonstrate any differences in patient demographics or baseline clinical characteristics. Pooled analysis of IP versus OP groups showed no difference in reduction in PUQE score at 48 hours (p=0.86). There was no difference in change in eating score (p=0.69), drinking score (p=0.77), wellbeing rating (p=0.64) or reduction in ketonuria (p=0.47) at 48 hours, with no difference in duration of index treatment episode (p=0.83) or re-attendances within 7 days (p=0.52). Conclusions Ambulatory management is an effective alternative to inpatient management of severe NVP. The trial also demonstrated that many women requiring treatment for HG have a strong preferences regarding treatment setting, which needs to be considered by care providers, especially given the psychological impact of HG.
Olanzapine Plus Fosaprepitant Standard Antiemetic Therapy in the Prevention of Chemotherapy-induced Nausea and Vomiting in Patients Receiving High Emetic Risk Multi-day Chemotherapy: a Multicenter, Ra
ClinicalTrials.gov study NCT04536558. IPD Sharing: NO. Countries: 1. Publications: 1.
Predictive Factors for Postoperative Pain, Nausea and Vomiting in Oncological Patients
ClinicalTrials.gov study NCT04889534. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Preoperative Chewing Gum on Anxiety and Postoperative Nausea and Vomiting, Gastrointestinal Function
ClinicalTrials.gov study NCT06603025. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Iranian Traditional Medicine Remedy on Chemotherapy Induced Nausea and Vomiting
ClinicalTrials.gov study NCT02787707. IPD Sharing: YES. Countries: 1. Publications: 1.
Do Nasogastric Tubes After Cardiac Surgery Reduce Nausea and Vomiting
ClinicalTrials.gov study NCT00193999. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Aprepitant for Chemotherapy Induced Nausea and Vomiting in Chinese Advanced Non-small Cell Lung Cancers
ClinicalTrials.gov study NCT02161991. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Risk Factors Analysis for Clinical Important Postoperative Nausea and Vomiting
ClinicalTrials.gov study NCT06445920. IPD Sharing: NO. Countries: 1. Publications: 14.
The Effect of Combining Aprepitant With Ondansetron in High-risk Patients for Postoperative Nausea and Vomiting
ClinicalTrials.gov study NCT01897337. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dextrose Effect on Postoperative Nausea and Vomiting (PONV)
ClinicalTrials.gov study NCT04726436. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of TAK-951 in Participants With Cyclic Vomiting Syndrome (CVS)
ClinicalTrials.gov study NCT06768658. IPD Sharing: YES. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.